COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
Angiotensin-converting enzyme 2 - Wikipedia
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect
Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial - The Lancet
What Is an Angiotensin Converting Enzyme Inhibitor? | Circulation
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library
Angiotensin-Converting Enzyme 2 - an overview | ScienceDirect Topics
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2- Angiotensin-(1-7)-Mas Receptor Axis | Hypertension
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) | Journal of Clinical Pathology
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent | Hypertension
Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors | PLOS ONE
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
Angiotensin-Converting Enzyme - Proteopedia, life in 3D
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Frontiers | Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2
Frontiers | Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
Angiotensin-converting enzyme in innate and adaptive immunity | Nature Reviews Nephrology
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection - ScienceDirect
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension
